StockCIK 1671502
Quoin Pharmaceuticals Ltd. (QNRX): Insider Trades and Fund Holdings
In the past 12 months, Quoin Pharmaceuticals Ltd. insiders reported 4 open-market purchases worth $280K and 0 sales worth $0.
4Insider buys, 12 months
$280KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 1, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 1 | Michael MyersCEO | ▲ BUY | $100K |
| Sep 1 | Denise P. CarterCOO | ▲ BUY | $100K |
| Sep 1 | Sally Bridget LawlorCFO | ▲ BUY | $50K |
| Sep 1 | Anthony James CulverwellDirector | ▲ BUY | $30K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Michael Myers | CEO | 1 | $100K | 0 | $0 |
| Denise P. Carter | COO | 1 | $100K | 0 | $0 |
| Sally Bridget Lawlor | CFO | 1 | $50K | 0 | $0 |
| Anthony James Culverwell | Director | 1 | $30K | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →